Once again BioNordika will be hosting the Nordic NGS Conference.
IDA Conference. Kalvebod Brygge 31-33, 1780 CPH
From 1800 DKK ex. VAt
2023 Nordic NGS conference will bring together influential professionals from the academic, industrial, and clinical
areas who work in various fields of NGS. The conference facilitates multiple opportunities for the exchange of
ideas and dialogue.
The Nordic NGS Conference 2023 is a continuation of the NGS conference that BioNordika arranged in 2018, which was a great success, and we want to accommodate this event once again. The idea behind this conference is to gather Nordic NGS researchers and have them present and discuss aspects of their research.
BioNordika wants to help facilitate research in NGS and offer Nordic researchers a platform to share their experiences, thereby helping to maintain the Nordic region as a spearhead in this field. Our hope is also that this Nordic NGS conference can be the starting of a Nordic NGS forum. We look forward to hosting this event and hope that you would like to participate.
The BioNordika Group was founded during 1986-1989. We currently employ around 40 people in the five offices in Sweden, Denmark, Norway and Finland with the idea of being an interface of science between advanced niche life science product/services suppliers and our customers in the Nordics. Scientific knowledge is a cornerstone in our structure, and we are highly educated to be able to support, discuss, and guide researchers to the right choices in their strive for excellent research.
BioNordika represents a unique combination of life science Premium Brands. Our wide offering of products and services focus in the areas of Cell & Molecular Biology, Immunology & Diagnostics, Instruments & Disposables and Custom Products & Projects.
We would like to express our sincere gratitude to all of our event suppliers and sponsors for their generous support. We are deeply appreciative of your commitment to our cause and for helping us reach our goals. Your support is greatly appreciated.